T/CGCPU 006-2023 Active Group standards

T/CGCPU 006-2023 I phase clinical trial capability evaluation specification

T/CGCPU 006-2023 I phase clinical trial capability evaluation specification

Publish Date: 2023-01-01 Implement Date: 2023-01-10 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CGCPU 006-2023
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2023-01-01
Implement Date: 2023-01-10

Scope

Main technical content: Foreword Introduction 1 Scope 2 Normative reference documents 3 Terms and definitions, acronyms 3.1 Terms and definitions 3.2 Acronyms 4 Evaluation content 4.1 Phase I clinical trial evaluation content 4.2 Phase I clinical trial capability evaluation 5 Evaluation experts 6 Evaluation process 6.1 Establishment of the evaluation process 6.2 Pre-evaluation workflow 6.3 On-site evaluation process 6.4 Issuance of the evaluation report 7 Result determination 7.1 Determination of clauses in the evaluation content 7.2 Evaluation conclusion Appendix A (Normative) Evaluation content and evaluation grades Appendix B (Normative) Specific requirements for the evaluation expert group References

Development Information

Related Standards

Contact Us